Cellectis Payables and Accrued Expenses (Quarterly) Analysis

Cellectis SA (CLLS)

3.76 +0.10 (+2.73%) USD | NASDAQ | Mar 04, 16:00

3.76 0.00 (0.00%) After-Hours: 20:00

View Payables and Accrued Expenses (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	Upgrade
DBV Technologies SA	Upgrade
Ascendis Pharma A/S	--
Akari Therapeutics Plc	Upgrade
Biodexa Pharmaceuticals Plc	Upgrade